Covered recipient · General Payments record
MICHAEL BARBARA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,730.73
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $162.45 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $52.43 | 3 |
| ABBVIE INC. | $22.69 | 1 |
| Abbott Laboratories | $22.17 | 1 |
| GlaxoSmithKline, LLC. | $18.83 | 1 |
| Amneal Pharmaceuticals LLC | $18.47 | 1 |
| Antares Pharma, Inc. | $14.14 | 1 |
| Lilly USA, LLC | $13.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.17 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125033617 | CMS |
| ABBVIE INC. | $22.69 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103277857 | CMS |
| Amneal Pharmaceuticals LLC | $18.47 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139180033 | CMS |
| Antares Pharma, Inc. | $14.14 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146448659 | CMS |
| GlaxoSmithKline, LLC. | $18.83 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116604276 | CMS |
| Lilly USA, LLC | $13.72 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135199521 | CMS |
| Novo Nordisk Inc | $17.52 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096650845 | CMS |
| Novo Nordisk Inc | $13.12 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097494022 | CMS |
| Novo Nordisk Inc | $21.79 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096604879 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.